Preclinical evaluation of the efficacy, pharmacokinetics and immunogenicity of JS-001, a programmed cell death protein-1 (PD-1) monoclonal antibody

Fu, J; Wang, F; Dong, LH; Zhang, J; Deng, CL; Wang, XL; Xie, XY; Zhang, J; Deng, RX; Zhang, LB; Wu, H; Feng, H; Chen, B; Song, HF

Song, HF (reprint author), Beijing Inst Radiat Med, Dept Pharmacol & Toxicol, Beijing 100850, Peoples R China.

ACTA PHARMACOLOGICA SINICA, 2017; 38 (5): 710

Abstract

JS-001 is the first monoclonal antibody (mAb) against programmed cell death protein-1 (PD-1) approved by the China Food and Drug Administration (CFDA)......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索